SEARCH

SEARCH BY CITATION

References

  • 1
    Choo Q., Kuo G., Weiner A., Overby L., Bradley D., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 35962.
  • 2
    Caiaffa W. T., Zocratto K. F., Osimani M. L., Martínez P. L., Radulich G., Latorre L. et al. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction 2011; 106: 14351.
  • 3
    Romano C. M., De Carvalho-Mello I. M., Jamal L. F., De Melo F. L., Iamarino A., Motoki M. et al.; VGDN Consortium. Social networks shape the transmission dynamics of hepatitis C virus. PLoS One 2010; 5: e11170.
  • 4
    Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29: 7481.
  • 5
    Scheinmann R., Hagan H., Lelutiu-Weinberger C., Stern R., Des Jarlais D. C., Flom P. L. et al. Non-injection drug use and hepatitis C Virus: a systematic review. Drug Alcohol Depend 2007; 89: 112.
  • 6
    Bastos F. I., Bongertz V., Teixeira S. L., Morgado M. G., Hacker M. A. Is human immunodeficiency virus/acquired immunodeficiency syndrome decreasing among Brazilian injection drug users? Recent findings and how to interpret them. Mem Inst Oswaldo Cruz 2005; 100: 916.
  • 7
    Rossi D., Pawlowicz M. P., Rangugni V., Singh D. Z., Goltzman P., Cymerman P. et al. The HIV/AIDS epidemic and changes in injecting drug use in Buenos Aires, Argentina. Cad Saude Publica 2006; 22: 74150.
  • 8
    Oliveira M. L., Yoshida C. F., Telles P. R., Hacker M. A., Oliveira S. A., Miguel J. C. et al. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies. Epidemiol Infect 2009; 137: 9709.